- Home
- Applications
- usa rhode island
- diabetes
Refine by
Diabetes Product Applications Available In Usa Rhode Island
52 applications found
Dehydroxy Mirabegron is an impurity of Mirabegron, a potent bladder relaxant and reagent for diabetes ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
Mirabegron is a potent bladder relaxant and reagent for diabetes remedy.https://www.bocsci.com/mirabegron-impurity-1-s-mirabegron-cas-1796931-48-0-item-473063.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
1 in 10 American have diabetes. Over 88 million Americans are pre-diabetic. Tesis Biosciences is working with physicians and research organizations to reverse this epidemic by helping to identify people with prediabetes, predict likelihood of diabetes to help prevent type 2 diabetes, identify and prevent diabetes complications, and improve the health of all people with diabetes. ...
ByTesis Biosciences based in Scottsdale, ARIZONA (USA)
Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type II diabetes. https://www.bocsci.com/saxagliptin-impurity-15-cas-1496712-39-0-item-479445.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
Sitagliptin is an dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
Of the three types of diabetes (Type 1, Type 2, and gestational), Type 2 accounts for over 90% of the total cases of diabetes. The increased prevalence of diabetes and obesity (a risk factor for Type 2 diabetes) has increased dramatically from 1994 to 2014 and is expected to grow. There are 86 million Americans with pre-diabetes (1/3rd of the population) of which 15% to 30% will develop type 2 diabetes in five ...
ByAlertgy based in Melbourne, FLORIDA (USA)
We are advancing a novel, oral approach to type 2 diabetes and obesity, two conditions of epidemic proportions in need of improved treatment options. ...
ByKallyope Inc. based in New York City, NEW YORK (USA)
CeQur Simplicity is revolutionizing mealtime insulin delivery for T1 and T2 diabetes patients on multiple daily injections (MDIs). Our 3-day wearable insulin patch removes mealtime insulin barriers, providing a convenient, discreet, and injection-free way for people with diabetes to deliver mealtime and correction boluses.4 ...
ByCeQur Simplicity SA based in Horw Luzern, SWITZERLAND
Exercise is part of a healthy lifestyle for everyone, and it’s especially important for people with diabetes. Exercise does not necessarily mean running a marathon or bench-pressing 300 pounds. ...
ByProdigy Diabetes Care, LLC based in Charlotte, NORTH CAROLINA (USA)
We are revolutionizing the way you will manage your Type 2 diabetes, applying leading edge sensor and materials technologies to detect blood sugar levels and present them to you through Alertgy ...
ByAlertgy based in Melbourne, FLORIDA (USA)
When you have type 2 diabetes, your body isn’t able to properly use insulin to bring glucose into your cells. ...
ByFractyl Health based in Lexington, MASSACHUSETTS (USA)
Bonalive advances the world’s transition to sustainable solutions for infection treatment and bone regeneration. We envision a world where diabetic foot osteomyelitis can be treated without local antibiotics – a smarter world, for a smarter life. ...
ByBonalive Biomaterials Ltd based in Turku, FINLAND
Prospective case controlled study of chronic diabetic foot ulcerations. N=10 DFU - Endoform plus NPWT vs N=10 DFU -NPWT alone. ...
ByAroa Biosurgery Limited based in Mangere, NEW ZEALAND
Diabetic macular edema is a complication of diabetes caused by fluid accumulation in the macula, or central portion of the eye. ...
ByLutronic Vision based in Billerica, MASSACHUSETTS (USA)
Indeed, The EMR software is the best one for the diabetologist practice as it is useful for designing diabetes-specific templates and assisting in the tracking of blood glucose levels immediately from the patient’s admission to the hospital. ...
ByHealthray Technologies PTV. Ltd. based in Surat, INDIA
At LRE, we develop and produce devices for exactly these scenarios, providing easy-to-use and reliable instruments for self-monitoring of lifestyle-associated diseases like diabetes, therapy control and screening of general health ...
ByLRE Medical based in Noerdlingen, GERMANY
Type 1 diabetes is a common chronic disease, affecting millions of people throughout the world, in which the immune system attacks the body’s own pancreatic cells, stopping the production of insulin. Though it was previously considered a childhood disease, type 1 diabetes is known to affect people at every age, and it has no ...
ByEli Lilly and Company based in Indianapolis, INDIANA (USA)
Glaukos is developing multiple micro-invasive, bioerodible, sustained-release drug delivery platforms designed to be used in the treatment of various retinal disease, including age-related macular degeneration (AMD) and diabetic macular ...
ByGlaukos Corporation based in San Clemente, CALIFORNIA (USA)
Diabetes occurs when glucose (sugar) builds up in the blood. This buildup causes an inability of the body to use the glucose for energy. This inability happens when the insulin does not function correctly. Many people believe that diabetes is a “sugar problem” but it is actually an “insulin ...
ByProdigy Diabetes Care, LLC based in Charlotte, NORTH CAROLINA (USA)